Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Anderson

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Blood|August 16, 2005
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myelomaSagar Lonial, Edmund K Waller, Paul G Richardson, et al.
Science Translational Medicine|December 3, 2025
Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injuryAhmed Gamal-Eldin Ibrahim, Alessandra Ciullo, Hiroaki Komuro, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Long-read sequencing identifies <i>FGF14</i> repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.
The Lancet. Respiratory Medicine|May 25, 2015
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional dataSu Yeon Kim, James Diggans, Dan Pankratz, et al.
Brain : a Journal of Neurology|December 2, 2025
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Blood|August 16, 2005
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myelomaSagar Lonial, Edmund K Waller, Paul G Richardson, et al.
Science Translational Medicine|December 3, 2025
Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injuryAhmed Gamal-Eldin Ibrahim, Alessandra Ciullo, Hiroaki Komuro, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Long-read sequencing identifies <i>FGF14</i> repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.
The Lancet. Respiratory Medicine|May 25, 2015
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional dataSu Yeon Kim, James Diggans, Dan Pankratz, et al.
Brain : a Journal of Neurology|December 2, 2025
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.
Pageof 8